Lv3
288 积分 2026-01-28 加入
Cancer burden and control in China: landscape, trends and challenges
20天前
已完结
Tumor-antigen-independent targeting of solid tumors by armored macrophage-directed anti-TREM2 CAR T cells
1个月前
已完结
Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial
1个月前
已完结
Gastric Cancer A Review
1个月前
已完结
Progress in the development of cytokine armoured CAR T cells
2个月前
已完结
Unlocking the potential of T cell engagers in solid tumors
2个月前
已完结
Claudin 18.2 as a novel therapeutic target
5个月前
已完结
Microenvironmental regulation of solid tumour resistance to CAR T cell therapy
6个月前
已完结
Still working at 107: supercentenarian study probes genetics of extreme longevity
6个月前
已完结
IL-9 signaling redirects CAR T cell fate toward CD8+ memory and CD4+ cycling states, enhancing antitumor efficacy
6个月前
已完结
皖公网安备34019202002308
